Susan J Dutton - JoVE Visualize

Showing results (11-20 of 77) with videos related to

Pageof 8

Sort By:

Trials|November 9, 2022

Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit ProgrammeKatie Mellor, James Harwood, Jennie Hejdenberg, et al.

The Bone & Joint Journal|January 1, 2020

Woodcast versus standard casting material for the immobilization of nonoperatively treated distal radial fracturesStephen Gwilym, Lucy Sansom, Ines Rombach, et al.

BMC Cancer|July 12, 2014

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancerSusan J Dutton, Nicola Kenealy, Sharon B Love, et al.

Trials|July 21, 2021

Statistical analysis plan for a pragmatic phase III randomised controlled trial examining behaviour change physiotherapy intervention to increase physical activity following hip and knee replacements: the PEP-TALK trialAlexander Ooms, Susan J Dutton, Scott Parsons, et al.

Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 9, 2019

Duration of Treatment Effect Should Be Considered in the Design and Interpretation of Clinical Trials: Results of a Discrete Choice ExperimentBethan Copsey, James Buchanan, Raymond Fitzpatrick, et al.

Trials|September 7, 2020

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trialIoana R Marian, Sally Hopewell, David J Keene, et al.

BMC Cancer|March 17, 2015

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndromeToby A Eyre, Ruth Clifford, Corran Roberts, et al.

Cost Effectiveness and Resource Allocation : C/E|February 9, 2023

Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudicationMandy Maredza, Kamran Khan, Ioana R Marian, et al.

The Bone & Joint Journal|April 27, 2021

Chronic pain with neuropathic characteristics after surgery for major trauma to the lower limb: prevalence, predictors, and association with pain severity, disability, and quality of life in the UK WHiST trialDavid J Keene, Ruth Knight, Julie Bruce, et al.

Trials|August 31, 2018

Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trialMichael M Schlüssel, David J Keene, Susan Wagland, et al.

Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:

Pageof 8

Trials|November 9, 2022

Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit ProgrammeKatie Mellor, James Harwood, Jennie Hejdenberg, et al.

The Bone & Joint Journal|January 1, 2020

Woodcast versus standard casting material for the immobilization of nonoperatively treated distal radial fracturesStephen Gwilym, Lucy Sansom, Ines Rombach, et al.

BMC Cancer|July 12, 2014

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancerSusan J Dutton, Nicola Kenealy, Sharon B Love, et al.

Trials|July 21, 2021

Statistical analysis plan for a pragmatic phase III randomised controlled trial examining behaviour change physiotherapy intervention to increase physical activity following hip and knee replacements: the PEP-TALK trialAlexander Ooms, Susan J Dutton, Scott Parsons, et al.

Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 9, 2019

Duration of Treatment Effect Should Be Considered in the Design and Interpretation of Clinical Trials: Results of a Discrete Choice ExperimentBethan Copsey, James Buchanan, Raymond Fitzpatrick, et al.

Trials|September 7, 2020

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trialIoana R Marian, Sally Hopewell, David J Keene, et al.

BMC Cancer|March 17, 2015

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndromeToby A Eyre, Ruth Clifford, Corran Roberts, et al.

Cost Effectiveness and Resource Allocation : C/E|February 9, 2023

Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudicationMandy Maredza, Kamran Khan, Ioana R Marian, et al.

The Bone & Joint Journal|April 27, 2021

Chronic pain with neuropathic characteristics after surgery for major trauma to the lower limb: prevalence, predictors, and association with pain severity, disability, and quality of life in the UK WHiST trialDavid J Keene, Ruth Knight, Julie Bruce, et al.

Trials|August 31, 2018

Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trialMichael M Schlüssel, David J Keene, Susan Wagland, et al.

Pageof 8